Neuphoria Therapeutics (NEUP) Cash & Current Investments (2020 - 2026)
Neuphoria Therapeutics (NEUP) posted Cash & Current Investments of $19.9 million for fiscal Q4 2026 (quarter ended Jun 30, 2026), up 40.0% from $14.21 million a year earlier and up 2.4% from the prior quarter.
Powered by 
Analysis
Neuphoria Therapeutics (NEUP) Cash & Current Investments (2020 - 2026) Analysis & Trends
Since fiscal Q4 2020, Neuphoria Therapeutics has reported Cash & Current Investments for 16 quarters.
- Annual Cash & Current Investments has increased for three consecutive fiscal years, though with a five-year compound annual growth rate of -2.2% (FY2021 to FY2026).
- In prior fiscal years, Neuphoria Therapeutics' Cash & Current Investments was $14.21 million in FY2025 (+12.7%), $12.61 million in FY2024 (+3.4%), $12.2 million in FY2023 (-49.3%) and $24.04 million in FY2022 (+7.9%).
- Quarterly Cash & Current Investments has run from a low of $4.34 million in fiscal Q2 2025 to a high of $24.04 million in fiscal Q4 2022 over five years.
- On a year-over-year basis, Cash & Current Investments has increased in each of the last six quarters, with growth averaging 73.9% over the last eight quarters.
- The strongest year-over-year quarter for Cash & Current Investments in the past five years was fiscal Q2 2026, with growth of 411.0%; the weakest was fiscal Q2 2025, with a decline of 57.2%.
- According to Business Quant data, Cash & Current Investments for the three prior fiscal quarters was $19.44 million (Q3 2026), $22.2 million (Q2 2026) and $13.65 million (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.76 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 7.14 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 9.92 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.97 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 11.70 Bn |
| 10 | Neuphoria Therapeutics | 431.33 Mn | 356.14 Mn | - | 19.90 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 19.90 Mn |
| Mar 31, 2026 | 19.44 Mn |
| Dec 31, 2025 | 22.20 Mn |
| Sep 30, 2025 | 13.65 Mn |
| Jun 30, 2025 | 14.21 Mn |
| Mar 31, 2025 | 17.04 Mn |
| Dec 31, 2024 | 4.34 Mn |
| Sep 30, 2024 | 8.08 Mn |
| Jun 30, 2024 | 12.61 Mn |
| Mar 31, 2024 | 8.43 Mn |
| Dec 31, 2023 | 10.15 Mn |
| Sep 30, 2023 | 8.14 Mn |
| Jun 30, 2023 | 12.20 Mn |
| Jun 30, 2022 | 24.04 Mn |
| Jun 30, 2021 | 22.28 Mn |
| Jun 30, 2020 | 3.00 Mn |
API Access
Neuphoria Therapeutics Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=NEUP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "NEUP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=NEUP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();